According to Becker's Review, a leading healthcare publication, Memorial Hospital has the opportunity to announce its ...

In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

Nursing home residents that receive Medicaid benefits may be affected by a change in federal poverty level standards, which are applied to eligibility ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

Ore., urged federal health regulators Friday to fix their mistake that’s unfairly cost St. Charles Health System $6 million over a nearly three-year period. In his letter to the Centers for Medicare & ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...